Clinical trials
Phase 2 Atrial Fibrillation trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2020 | 1 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Advanz Pharma | 1 |
| Astellas Pharma Inc | 1 |
| Bayer | 1 |
| GlaxoSmithKline | 1 |
| Hospital Universitari de Bellvitge | 1 |
| Menarini Group | 1 |
| Pierre Fabre Medicament | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Atrial Fibrillation | 7 |
| Stroke | 2 |
| Arrhythmias, Cardiac | 1 |
| Cardiovascular Diseases | 1 |
| Ischemic Attack, Transient | 1 |
| Thromboembolism | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.